Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

an class="prnews_span">(166)Deferred revenue 

7,636(2,818)Other liabilities 

(6,557)(1,223)Net cash used in operating activities 

(71,375)(72,448)Cash flows from investing activities:Maturities of investments 

118,777200,477Purchases of investments 

(166,496)(109,400)Purchases of property and equipment 

(5,192)(794)Net cash (used in) provided by investing activities 

(52,911)90,283Cash flows from financing activities:Payment of capital lease obligations 

(1,650)(1,466)Repayment of proceeds from sale of future royalties

(7,000)(3,000)Issuance of common stock, net of issuance costs

116,601-Proceeds from shares issued under equity compensation plans

7,9612,621Net cash provided by (used in) financing activities 

115,912(1,845)Effect of exchange rates on cash and cash equivalents 

65Net (decrease) increase in cash and cash equivalents 

(8,368)15,995Cash and cash equivalents at beg
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming Rodman & Renshaw 17 th Annual Global ... New York City .  Dr. Michael ... overview on September 9, 2015. Presentation ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... 2011 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... EST on Friday, January 6, 2012 at the Millennium Hotel, ... Executive Officer, Patrick G. LePore, and other members of the ... growth strategy, current products and pipelines, and business outlook to ...
... Calif., Dec. 5, 2011  Beyond Lucid Technologies, Inc., ... disaster management, and First Response industries, today announced ... the mHealth Summit, and the publication of a ... connect ambulances with hospitals via telemedicine. ...
Cached Medicine Technology:Beyond Lucid Technologies Advances Telemedicine for EMS Providers 2Beyond Lucid Technologies Advances Telemedicine for EMS Providers 3
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... Consumer Health Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, ... hazardous waste handling rules constantly evolving in the consumer goods industry, it can ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily stressors and distractions ... and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons ... the island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at the ... Speakers at the 2015 symposium are doctors and researchers at the top of ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal ... under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best ... Information Services, Inc. (AIS), will detail which deals are attracting the most government ...
(Date:9/3/2015)... ... ... AlignLife of Wauwatosa is excited to hold its annual Coat Drive ... who don't have the ability to buy a jacket warm enough for the winters ... to help those in need." , This is AlignLife's third annual Coat Drive. Each ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
... reported vector-borne disease in the United States, with the majority ... decades since the agent of the disease, the spirochete ... identified. However, the number of Lyme disease cases have steadily ... issuue of the Journal of Medical Entomology called ...
... Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Some people ... chemotherapy, and a mutation in the so-called TFAP2E gene may ... Knowing which patients carry the mutation might help ... researchers said. "In our study, we identified a gene ...
... HealthDay Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Small ... States in recent years are charted in a new report. ... 1.8 percent a year in men and 1.6 percent a year ... from 1990 through 2008, death rates plunged almost 23 percent for ...
... When patients with diabetes experience interruptions in health - insurance ... and vaccines they need to protect their health. A new ... free or reduced-cost medical care at federally funded safety net ... National Institutes of Health and findings published online in the ...
... Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Remember ... steep, but you took the plunge and whizzed downward. ... higher and hanging by your knees at the pinnacle. ... Low sliding boards, safer plastic climbers and fence-protected platforms ...
... Remick, M.D. lead investigators at the Los Angeles ... are spearheading a statewide, web-based survey scheduled to ... the pediatric emergency readiness of hospital emergency departments (EDs). ... this project also represents an enormous quality improvement initiative ...
Cached Medicine News:Health News:How can Lyme disease be prevented and controlled? 2Health News:Gene Mutation Linked to Chemo-Resistant Colon Cancer 2Health News:Cancer Incidence, Death Rates Continue to Drop: Report 2Health News:Cancer Incidence, Death Rates Continue to Drop: Report 3Health News:Kaiser Permanente study finds continuous health coverage essential for patients managing diabetes 2Health News:'Safety-First' Playgrounds Linked to Bored, Inactive Kids: Study 2Health News:'Safety-First' Playgrounds Linked to Bored, Inactive Kids: Study 3Health News:LA BioMed investigators lead first survey to determine hospital EDs' pediatric readiness 2
... The STart 4 semi-automated hemostasis analyzer ... electro-mechanical clot detection (Viscosity-based Detection System). ... icteric or other optically turbid samples ... offers programmable and preprogrammed assays with ...
... The STA is a fully-automated, ... chromogenic and immunological assays in true ... method of sample management offers high ... samples without the need to interrupt ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
... The Electra 1800C ... coagulation system that maximizes ... risks to the operator ... It is equipped with ...
Medicine Products: